*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
A Study on the Use of Evidence Based Therapy (EBT) in the Treatment of Type 2 Diabetes Mellitus in a Private Healthcare Facility in Malaysia

Author: , BAMA VV MENON, YAMAN WALID KASSAB, HANISH SINGH JEYASINGH CHELLAMMAL, ANANDARAJAGOPAL KALUSALINGAM, ABDULLAH KHAN
Abstract: The purpose of this study was to access the prescribing pattern and determine the sociodemographic and clinical predictors of prescribing of antidiabetics in a private hospital. This study also aimed to evaluate prescription adherence to the Clinical Practice Guideline (CPG) for the Management of Type 2 Diabetes Mellitus (T2DM). This cross-sectional study included a random sample of 115 patients selected from the patients referred to the diabetic nurse educator in a private hospital. A retrospective data collection method was adopted with a specially devised data collection sheet, which consists of four parts. Poor glycaemic control was observed in 66.1% of patients, with a mean glycosylated hemoglobin A1c (HbA1c) of 9.3 ± 2.2. A Significant correlation was found between HbA1c and the number of antidiabetics prescribed (p =0.047). Metformin was the most prescribed antidiabetic, followed by Gliclazide and Sitagliptin. Insulin usage was limited to 15.7% only. The most commonly combined dual therapy was Metformin with Gliclazide, followed by Metformin with Sitagliptin. Significant negative predictors of the prescription of Metformin were patients with renal dysfunction and taking beta-blockers for the treatment of comorbidities. The involvement of coronary artery disease enhanced the probability of prescribing Sitagliptin by 47 (95 per cent CI 1.1-19.1). Overall, in only about 48 per cent of patients, adherence to guidelines could be seen. In conclusion, this research revealed that adherence to Malaysian CPG was found to be low for T2DM management. In this private hospital, Dipeptidyl Peptidase 4 (DPP4) inhibitors were commonly used, although insulin usage was minimal.
Keyword: Prescribing pattern, Evidence based therapy, Type 2 Diabetes Mellitus, glycaemic control
DOI: https://doi.org/10.31838/ijpr/2021.13.03.099
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free